PubRank

Mary E Marquart

Author PubWeight™ 26.79‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Effectiveness of ciprofloxacin, levofloxacin, or moxifloxacin for treatment of experimental Staphylococcus aureus keratitis. Antimicrob Agents Chemother 2004 1.01
2 The region of the HSV-1 latency-associated transcript required for epinephrine-induced reactivation in the rabbit does not include the 2.0-kb intron. Virology 2002 0.97
3 Ocular virulence of capsule-deficient streptococcus pneumoniae in a rabbit keratitis model. Invest Ophthalmol Vis Sci 2005 0.88
4 Pseudomonas aeruginosa small protease (PASP), a keratitis virulence factor. Invest Ophthalmol Vis Sci 2013 0.87
5 The Streptococcus pneumoniae capsule is required for full virulence in pneumococcal endophthalmitis. Invest Ophthalmol Vis Sci 2011 0.87
6 Protection from Streptococcus pneumoniae keratitis by passive immunization with pneumolysin antiserum. Invest Ophthalmol Vis Sci 2008 0.86
7 Corneal virulence of Pseudomonas aeruginosa elastase B and alkaline protease produced by Pseudomonas putida. Curr Eye Res 2007 0.85
8 Molecular analysis of Pseudomonas aeruginosa protease IV expressed in Pseudomonas putida. Invest Ophthalmol Vis Sci 2003 0.84
9 Modulation of immune signaling, bacterial clearance, and corneal integrity by toll-like receptors during streptococcus pneumoniae keratitis. Curr Eye Res 2013 0.84
10 Properties of PASP: a Pseudomonas protease capable of mediating corneal erosions. Invest Ophthalmol Vis Sci 2009 0.83
11 Assessment of Streptococcus pneumoniae capsule in conjunctivitis and keratitis in vivo neuraminidase activity increases in nonencapsulated pneumococci following conjunctival infection. Curr Eye Res 2010 0.83
12 A comparison of pneumolysin activity and concentration in vitro and in vivo in a rabbit endophthalmitis model. Clin Ophthalmol 2008 0.83
13 Age-related differences in rabbits during experimental Staphylococcus aureus keratitis. Invest Ophthalmol Vis Sci 2007 0.83
14 Active Immunization with Pneumolysin versus 23-Valent Polysaccharide Vaccine for Streptococcus pneumoniae Keratitis. Invest Ophthalmol Vis Sci 2011 0.82
15 Pseudomonas aeruginosa protease IV: a corneal virulence factor of low immunogenicity. Ocul Immunol Inflamm 2005 0.81
16 Localization of PcsB of Streptococcus pneumoniae and its differential expression in response to stress. J Bacteriol 2007 0.80
17 "Boom" and "Bust" cycles in virus growth suggest multiple selective forces in influenza a evolution. Virol J 2011 0.80
18 The cholesterol-dependent cytolysin pneumolysin from Streptococcus pneumoniae binds to lipid raft microdomains in human corneal epithelial cells. PLoS One 2013 0.79
19 Immunization with pneumolysin protects against both retinal and global damage caused by Streptococcus pneumoniae endophthalmitis. J Ocul Pharmacol Ther 2010 0.79
20 Development of a Streptococcus pneumoniae keratitis model in mice. Ophthalmic Res 2009 0.79
21 Identification of the active site residues of Pseudomonas aeruginosa protease IV. Importance of enzyme activity in autoprocessing and activation. J Biol Chem 2002 0.78
22 Pathogenesis of A Clinical Ocular Strain of Streptococcus pneumoniae and the Interaction of Pneumolysin with Corneal Cells. J Bacteriol Parasitol 2011 0.78
23 Pathogenesis of Staphylococcus in the rabbit anterior chamber. Invest Ophthalmol Vis Sci 2005 0.77
24 Moxifloxacin and cholesterol combined treatment of pneumococcal keratitis. Curr Eye Res 2010 0.77
25 Comparative efficacy of besifloxacin and other fluoroquinolones in a prophylaxis model of penicillin-resistant Streptococcus pneumoniae rabbit endophthalmitis. J Ocul Pharmacol Ther 2010 0.77
26 Comparison of besifloxacin, gatifloxacin, and moxifloxacin against strains of pseudomonas aeruginosa with different quinolone susceptibility patterns in a rabbit model of keratitis. Cornea 2011 0.77
27 Efficacy of besifloxacin in an early treatment model of methicillin-resistant Staphylococcus aureus keratitis. J Ocul Pharmacol Ther 2010 0.76
28 Efficacy of besifloxacin in a rabbit model of methicillin-resistant Staphylococcus aureus keratitis. Cornea 2009 0.76
29 Quantitative comparison of fluoroquinolone therapies of experimental gram-negative bacterial keratitis. Curr Eye Res 2004 0.76
30 The effectiveness of lysostaphin therapy for experimental coagulase-negative Staphylococcus endophthalmitis. Curr Eye Res 2006 0.76
31 Effective release of a broad spectrum antibiotic from elastin-like polypeptide-collagen composite. J Biomed Mater Res A 2014 0.76
32 Differential bacterial gene expression during experimental pneumococcal endophthalmitis. Ophthalmic Res 2015 0.75
33 Passive immunization with Pneumovax® 23 and pneumolysin in combination with vancomycin for pneumococcal endophthalmitis. BMC Ophthalmol 2013 0.75